|
P2-091 E-T02A-0288
Biomaterials processing and biofabrication
-
3D Printing and additivie manufacturing
Effect of the filler proportion and its optical properties on the dimensional stability and mechanical properties of 3d printed resin
Pei-Yu Hou
|
|
P2-092 P-T02A-3079
Biomaterials processing and biofabrication
-
3D Printing and additivie manufacturing
Collagen for neural tissue engineering: materials, strategies, and challenges
Wenhui Huang
|
|
P2-093 O-T02B-3590
Biomaterials processing and biofabrication
-
Bioprinting and bionik
Tailoring aqueous two-phase system inks for enhanced cellular functionality and alignment in 3D bioprinted tissues
Martina Marcotulli
|
|
P2-094 P-T02A-2355
Biomaterials processing and biofabrication
-
3D Printing and additivie manufacturing
Elucidating 3D Bioprinted Gelatine-Human Skin Dermal Fibroblasts Stability for Wound Dressing Applications via AKT Signalling Pathways
NUR AIFA ASYHIRA KHAIRUL NIZAM
|
|
P2-095 P-T02A-1141
Biomaterials processing and biofabrication
-
3D Printing and additivie manufacturing
Process for Fabricating 3D Printed Scaffolds Based on Sodium Alginate and Graphene Oxide for Personalized Tissue Engineering.
Alin Toader
|
|
P2-096 P-T02A-1272
Biomaterials processing and biofabrication
-
3D Printing and additivie manufacturing
3D printing of porous beta-titanium alloys TiNbTaSn
Zdenek Tolde
|
|
P2-097 P-T02A-1404
Biomaterials processing and biofabrication
-
3D Printing and additivie manufacturing
Application of 3D printing bone scaffolds grafted with BMP-2 on bone tissue regeneration
CHUN HSU YAO
|
|
P2-098 P-T02A-2194
Biomaterials processing and biofabrication
-
3D Printing and additivie manufacturing
Extrusion-based 3D bioprinting from bench to bedside applications in bone tissue engineering using platelet-rich plasma and scaffolding materials
Dongxu Ke
|
|
P2-099 P-T02A-4087
Biomaterials processing and biofabrication
-
3D Printing and additivie manufacturing
Bioprinting of patient-derived in vitro tumor organoid model: establishment, evaluation and anti-cancer drug testing
Shuangshuang Mao
|
|
P2-100 O-T02B-3626
Biomaterials processing and biofabrication
-
Bioprinting and bionik
Development of a new gelatin methacrylate-fibrinogen-based bioink for skeletal muscle tissue engineering
Diego Trucco
|
|
P2-101 P-T03C-0218
Biomaterials for theranostics
-
Drug delivery
Synthesis of High Encapsulation Efficiency and Homogeneity Solid Lipid Nanoparticles containing Curcumin based on Microfluidics
Jun-Won Kook
|
|
P2-102 P-T03C-2215
Biomaterials for theranostics
-
Drug delivery
Development of Composite Microneedle Patch and Bio-patch
Dae Ryeong Lee
|
|
P2-103 P-T03C-2233
Biomaterials for theranostics
-
Drug delivery
Carbon-based nanoparticles for anti-cancer drug delivery
Hongjae Kim
|
|
P2-104 P-T03C-2610
Biomaterials for theranostics
-
Drug delivery
Hyaluronated Lipid Nano Particles for mRNA Vaccines
Mungu Kim
|
|
P2-105 P-T03C-2714
Biomaterials for theranostics
-
Drug delivery
Development of microfluidic chip-based lipid nanoparticles with improved membrane stability through structural proteins to improve bioavailability of hydrophobic drug
Yoseph Seo
|
|
P2-106 P-T03C-3007
Biomaterials for theranostics
-
Drug delivery
Thermo-sensitive and Charged Polypeptide for Controlled Release of Lixisenatide
Park Jinkyung
|
|
P2-107 O-T03C-1449
Biomaterials for theranostics
-
Drug delivery
Preparation of Polymeric Nanoparticles containing Aconite Root for the treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN)
Tae Eon Park
|
|
P2-108 P-T03C-2602
Biomaterials for theranostics
-
Drug delivery
Nano-micelle generating dissolving microneedles containing doxorubicin for inhibiting metastatic melanoma
Siyan Lyu
|
|
P2-109 P-T03C-2370
Biomaterials for theranostics
-
Drug delivery
Development of spontaneously binding recombinant fusion protein systems for dual-drug delivery
Chanho Park
|
|
P2-110 P-T03C-3313
Biomaterials for theranostics
-
Drug delivery
Dual drug delivery of polyphenol carbon dot and pilocarpine using porous contact lenses for glaucoma treatment
SeoHyun Kim
|
|
P2-111 O-T03C-0476
Biomaterials for theranostics
-
Drug delivery
Protein Nanoparticles with Tumor Environment-Inducible Underwater Adhesiveness for Pancreatic Cancer Therapy
Hyeokjun Lee
|
|
P2-112 E-T03C-1348
Biomaterials for theranostics
-
Drug delivery
Adipose Tissue Targeting Peptide-Glycyrrhizin Conjugate for Inflammation Suppression and Obesity Treatment
Lia Priscilla
|
|
P2-113 P-T03C-2445
Biomaterials for theranostics
-
Drug delivery
Polyethylenimine-modified cationic hydroxyethyl cellulose derivatives for anticancer drug/siRNA co-delivery systems
Seoyeon Park
|
|
P2-114 P-T03C-1810
Biomaterials for theranostics
-
Drug delivery
Exosome Membrane-Integrated Microbubbles: Augmenting Stability and Drug Delivery Efficacy for Ultrasound Contrast Agents
Jooho MOON
|
|
P2-115 P-T03C-1910
Biomaterials for theranostics
-
Drug delivery
Phospholipid nanotubes conjugated lipid nanoparticles for efficient gene delivery
Minho Lee
|
|
P2-116 E-T03C-1146
Biomaterials for theranostics
-
Drug delivery
Iontophoretic ocular delivery of latanoprost loaded PLGA nanoparticles via skin-attached electrodes
Chang Hee Min
|
|
P2-117 P-T03C-1437
Biomaterials for theranostics
-
Drug delivery
Co-delivery of berberine and paclitaxel by CXCR4-targeted core/shell nanocarrier to improve breast cancer treatment
Yeonwoo Jang
|
|
P2-118 P-T03C-3270
Biomaterials for theranostics
-
Drug delivery
Quantitative Analysis into Nanocarrier-Drug Interactions for Advanced Glaucoma Therapeutics
Serim Byun
|
|
P2-119 P-T03C-2922
Biomaterials for theranostics
-
Drug delivery
Hyaluronic acid-coated agmatine-based nanocomplex for nucleus-targeted anticancer therapy
Hyun Ji Cho
|
|
P2-120 P-T03C-1904
Biomaterials for theranostics
-
Drug delivery
Delivery of Zwitterion conjuated with Nitric oxide and Dexamethasone acting on Mucus Layer for Enhanced Treatment of ARDS
Hye-Jin Lee
|
Login
